Arecor

Arecor is a clinical-stage biopharmaceutical company based in Cambridge, UK, focused on developing enhanced therapeutic medicines for diabetes and other cardiometabolic diseases. The company leverages its proprietary Arestat® technology platform to improve the stability, delivery, and performance of existing drugs, particularly insulins and peptides. Its strategy includes both a proprietary pipeline and partnerships with pharmaceutical and medtech companies.